Factbox-New U.S. stock listings fail to impress in turbulent 2022
2022.05.06 20:32
Traders work on the trading floor at the New York Stock Exchange (NYSE) in Manhattan, New York City, U.S., March 7, 2022. REUTERS/Andrew Kelly
(Reuters) – Eye care company Bausch + Lomb’s decision to price its initial public offering below range dashed the hopes of a revival in the market for news issues as inflation and geopolitical uncertainties play spoilsport.
The few companies that have managed to list their shares on Wall Street recently have seen lukewarm reception.
Here is a list of stock performances of the biggest IPOs in 2022:
U.S. listings Month of Capital Stock
in 2022 listing raised performance
since debut
TPG Inc January $1 bln -21.2%
Excelerate April $442 mln -7.2%
Energy Inc
Credo January $200 mln -9.8%
Technology
Group Holding
Ltd
HilleVax Inc April $230 mln -13.2%
CinCor Pharma January $194 mln +18.7%
Inc
Amylyx January $190 mln -56%
Pharmaceuticals
Inc
Source: Refinitiv
